Share on LinkedInShare on LinkedIn

PODCAST · 21 APRIL 2022

IP Insights: Supplementary Protection Certificates (Podcast)

Bardehle Pagenberg
Bardehle Pagenberg
Contributor
Bardehle Pagenberg

Bardehle Pagenberg

IP practitioners with technical expertise As one of Europe’s leading IP law firms, BARDEHLE...

View firm profile
Explore more from Bardehle Pagenberg

Today, we will discuss some recent developments regarding Supplementary Protection Certificates or, in short: SPCs.

GermanyIntellectual Property

Read our IP Brochure on supplementary protection certificates.

Today, we will discuss some recent developments regarding Supplementary Protection Certificates or, in short: SPCs. An SPC is a discrete protective right that prolongs the protection conferred by a patent for a medicinal product or a plant protection product for a certain period of time in view of the marketing authorization procedure that these products need to undergo prior to their marketing. SPCs have been hotly debated since their introduction in the 1990s by an EU regulation. Why is that? Because many medicinal products yield their profit only at the end of the patent term and beyond that - which is then subject to protection by an SPC. Many questions, particularly regarding granting requirements were referred, over the years, to the European Court of Justice. Among all, the seemingly simple question of "Is the product which forms the subject matter of the SPC protected by the

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from